-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Evolutionary Genomics, Inc. quarterly/annual Depreciation history and growth rate from 2014 to 2022.
- Evolutionary Genomics, Inc. Depreciation for the quarter ending December 31, 2022 was $3.69K, a 54% decline year-over-year.
- Evolutionary Genomics, Inc. Depreciation for the twelve months ending December 31, 2022 was $14.7K, a 54% decline year-over-year.
- Evolutionary Genomics, Inc. annual Depreciation for 2022 was $14.7K, a 54% decline from 2021.
- Evolutionary Genomics, Inc. annual Depreciation for 2021 was $32.1K, a 15.9% decline from 2020.
- Evolutionary Genomics, Inc. annual Depreciation for 2020 was $38.1K, unchanged from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)